Newsfile Corp
09 Jul 2026, 22:54 UTC · 8w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
ADMA Biologics is accused of using channel stuffing to artificially inflate revenue figures. — Allegations of revenue manipulation via channel stuffing strike at the core of financial integrity and typically lead to significant valuation corrections.
-0.80A securities class action lawsuit alleges ADMA Biologics lacked adequate internal controls and engaged in undisclosed related party transactions. — Failure in internal controls and undisclosed conflicts of interest suggest systemic governance risks and potential for further financial irregularities.
-0.60The Rosen Law Firm has set a deadline of August 10, 2026, for investors to apply as lead plaintiff in the ADMA Biologics class action. — While procedural, the movement toward establishing a lead plaintiff formalizes the litigation process and maintains negative sentiment around the stock.
-0.20Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is facing a securities class action lawsuit alleging channel stuffing, undisclosed related party transactions, and lack of internal controls.
The company is mentioned as the subject of a securities class action lawsuit.
The company is mentioned as the subject of a securities class action lawsuit.
Mentioned as a leader in AI activity engagement with corporate news releases.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
1d ago
